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Abstract
During the process of endochondral bone formation, chondrocytes and osteoblasts mineralize their extracellular matrix by pro-
moting the formation of hydroxyapatite (HA) seed crystals in the sheltered interior of membrane-limited matrix vesicles (MVs). 
Ion transporters control the availability of phosphate and calcium needed for HA deposition. The lipidic microenvironment in 
which MV-associated enzymes and transporters function plays a crucial physiological role and must be taken into account 
when attempting to elucidate their interplay during the initiation of biomineralization. In this short mini-review, we discuss the 
potential use of proteoliposome systems as chondrocyte- and osteoblast-derived MVs biomimetics, as a means of reconstitut-
ing a phospholipid microenvironment in a manner that recapitulates the native functional MV microenvironment. Such a system 
can be used to elucidate the interplay of MV enzymes during catalysis of biomineralization substrates and in modulating in vitro 
calcification. As such, the enzymatic defects associated with disease-causing mutations in MV enzymes could be studied in an 
artificial vesicular environment that better mimics their in vivo biological milieu. These artificial systems could also be used for 
the screening of small molecule compounds able to modulate the activity of MV enzymes for potential therapeutic uses. Such a 
nanovesicular system could also prove useful for the repair/treatment of craniofacial and other skeletal defects and to facilitate 
the mineralization of titanium-based tooth implants.
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Matrix vesicles
Mineralization of cartilage and bone occurs by physi-
cochemical and biochemical processes that facilitate the 
deposition of hydroxyapatite (HA) in specific areas of the 
extracellular matrix (ECM). Experimental evidence has 
pointed to the presence of HA crystals along collagen fibrils 
in the ECM (reviewed in Ref. 1) and also within the lumen of 
chondroblast- and osteoblast-derived matrix vesicles (MVs) 
(reviewed in Ref. 2). Investigators in the bone mineralization 
field are usually divided in supporting the collagen- versus 
the MV-mediated mechanism of mineralization, but we see 
no incompatibility between these mechanisms. Our work-
ing model is that bone mineralization is first initiated within 
the lumen of MVs and, in a second step, HA crystals grow 
beyond the confines of the MVs and become exposed to 
the extracellular milieu where they continue to propagate 
along collagen fibrils. This process is coordinated by the 
balanced action of promoters and inhibitors of calcification 
(reviewed in Ref. 3). 
It is currently believed that MVs have at least two princi-
pal roles in initiating calcification: 1) MV enzymes regulate 
the ratio of phosphate (Pi) to inorganic pyrophosphate (PPi) 
in the intra- and extravesicular fluid, and 2) MV proteins and 
lipids, including acidic phospholipids, serve as nucleation 
sites for apatite deposition (4). PPi, derived both from 
ectoplasmic PC-1/nucleotide pyrophosphatase/phosphodi-
esterase-1 (NPP1)-catalyzed production from extracellular 
nucleoside triphosphates (5) and by intracellular export 
via the ankylosis protein (ANK) transporter, inhibits matrix 
mineralization (6). This inhibition is released through the 
action of tissue-nonspecific alkaline phosphatase (TNAP), 
which hydrolyzes PPi, thus simultaneously removing the 
inhibitor and providing additional Pi for mineral formation 
(7,8). Mineralization is said to proceed in two phases: an 
initial formation of apatite within MVs, and a subsequent 
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propagation phase in the matrix (2,9). According to this 
mechanism, Ca2+ enters MVs via an annexin channel and 
phosphate enters via a type III Na+-dependent phosphate 
transporter (PiT), and possibly other Pi-transporters, to 
form apatite within MVs (10,11). Acidic phospholipids 
and other MV components are thought to nucleate these 
intravesicular nanocrystals (12-14). Subsequently, the 
intravesicular mineral grows beyond the confines of MVs 
onto a collagenous matrix aided by a number of promoters 
and inhibitors of calcification (3).
MV enzymes, channels and transporters
MVs are complex nanovesicles. Three recent proteomic 
papers have provided a first indication of just how diverse 
their proteomic constitution is (15-17). Here we will only refer 
to some of the enzymes, channels and transporters that 
have been implicated in the biological function of MVs to 
date. Figure 1 illustrates the proposed role of the molecules 
that are described in more detail below. 
TNAP is the only tissue-nonrestricted isozyme of a 
Figure 1. Schematic representation of the molecules involved in matrix vesicle (MV)-mediated calcification including the most favored 
enzymatic reactions of their putative physiological substrates. This is a modified figure based on the one published in Ciancaglini et 
al. (54). Hydroxyapatite seed crystals are formed in the sheltered interior of MVs favored by the inorganic phosphate (Pi)-generating 
ability of PHOSPHO1, which uses phosphocholine (Pcho) and phosphoethanolamine (PEA) as substrates, as well as by the function of 
Pi-transporters (PiT) and annexins that mediate Ca2+ ion influx. Tissue-nonspecific alkaline phosphatase (TNAP) has a major role both 
as a PPiase and as an ATPase/ADPase and thus participates in the calcification process by restricting the concentration of extracellular 
PPi while also contributing to the Pi pool available for calcification. PC-1/nucleotide pyrophosphatase phosphodiesterase 1 (NPP1) can 
act as a backup PPiase and also ATPase, particularly in the absence of TNAP. Thick lines indicate the most favored reactions, while 
dotted lines indicate alternative backup enzymatic reactions. Outside the MVs, collagen acts as a primary scaffold for the deposition 
of hydroxyapatite crystals. 
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family of four homologous human AP genes (EC. 3.1.3.1) 
(reviewed in Ref. 18). Expressed as an ecto-enzyme 
anchored via a phosphatidylinositol glycan moiety, TNAP 
has been demonstrated to play an essential physiological 
role during bone matrix mineralization. A deficiency in the 
TNAP isozyme causes the inborn error of metabolism known 
as hypophosphatasia and the study of this disease has 
provided the best evidence of the importance of TNAP for 
bone mineralization (19). The severity of hypophosphatasia 
is variable and is modulated by the nature of the TNAP 
mutation (18,19). The clinical severity of hypophosphata-
sia patients varies widely. The different syndromes, listed 
from the most severe to the mildest forms, are: perinatal 
hypophosphatasia, infantile hypophosphatasia, childhood 
hypophosphatasia, adult hypophosphatasia, odontohypo-
phosphatasia, and pseudohypophosphatasia (19). These 
phenotypes range from complete absence of bone miner-
alization and stillbirth to spontaneous fractures and loss of 
decidual teeth in adult life. Inactivation of the mouse TNAP 
gene (Akp2) phenocopies the infantile form of human hy-
pophosphatasia (18). Biochemically, hypophosphatasia is 
diagnosed by a low serum TNAP level as well as accumula-
tion of the phosphocompounds inorganic pyrophosphate 
(PPi), pyridoxal-5’-phosphate and phosphoethanolamine 
(PEA) (18,19). 
In bone, TNAP is confined to the cell surface of os-
teoblasts and chondrocytes, including the membranes of 
their shed MVs (2). It has been proposed that the role of 
TNAP in the bone matrix is to generate the inorganic phos-
phate needed for HA crystallization. However, TNAP has 
also been shown to hydrolyze the mineralization inhibitor 
PPi, thus facilitating mineral precipitation and growth (2). 
Electron microscopy revealed that TNAP-deficient MVs, 
in both humans and mice, contain apatite crystals, but 
that extravesicular crystal propagation is delayed (20,21). 
This growth retardation could be due to either the lack of 
TNAP’s pyrophosphatase function or the lack of inorganic 
phosphate generation. Our recent studies have provided 
compelling proof that the major function of TNAP in bone 
tissue consists of hydrolyzing PPi to maintain a proper con-
centration of this mineralization inhibitor to ensure normal 
bone mineralization (7,8,22). 
A primary inhibitor of ECM mineralization is extracel-
lular PPi (23), primarily generated by the members of the 
nucleotide pyrophosphatase/phosphodiesterase (NPP) 
family of isozymes. Nucleotide pyrophosphatase/phos-
phodiesterase-1 (NPP1) is plasma membrane-bound, 
whereas autotaxin (NPP2) is secreted and B10 (NPP3) is 
abundant in intracellular spaces (5). All three isozymes are 
expressed in a wide variety of tissues, including bone and 
cartilage and they all share the ability to hydrolyze diesters 
of phosphoric acid into phosphomonoesters, primarily ATP 
to AMP and PPi, and/or ADP to adenosine (5). Similar to 
skeletal TNAP expression, NPP1 is highly abundant on the 
surfaces of osteoblasts and chondrocytes as well as on the 
membrane of their MVs (5). NPP1 has a role in inhibiting 
HA precipitation by its PPi-generating property (5). 
Similar to NPP1, ANK has a role in mineralization by 
contributing to the extracellular supply of PPi. However, 
unlike NPP1, ANK appears to function as a transmembrane 
PPi-channeling protein, allowing PPi molecules to pass 
through the plasma membrane from the cytoplasm to the 
outside of the cell (6). ANK protein is detectable in many tis-
sues, yet its expression is particularly strong in the cartilage 
of joints (6). Cell surfaces of osteoblasts and chondrocytes 
appear to be abundant in ANK protein.
Mice deficient in NPP1 (Enpp1-/-) or ANK (ank/ank) 
develop soft tissue calcification, including vascular calcifica-
tion, resulting from the reduced production or transport of 
PPi (7,8,22), while mice deficient in TNAP function (Akp2-/-) 
display rickets and osteomalacia due to an arrest in the 
propagation of HA crystals outside the MVs caused by 
an increase in extracellular PPi concentrations (2,7,8,21). 
HA crystals are still present in TNAP-deficient MVs and 
it has been proposed that the soluble MV phosphatase 
PHOSPHO1 might be involved in increasing the local in-
travesicular concentration of Pi to change the Pi/PPi ratio 
to favor precipitation of HA seed crystals (24). 
PHOSPHO1 is a member of the haloacid dehalogenase 
superfamily of Mg2+-dependent hydrolases, first identified in 
chick embryos, that is expressed at levels 100-fold higher 
in mineralizing chondrocytes than in non-mineralizing tis-
sues and shows high phosphohydrolase activity towards 
PEA and phosphocholine (PCho) (25). The use of small 
compounds to inhibit its activity in Akp2-/- MVs leads to a 
significance decrease in in vitro MV-mediated calcification 
(24), implicating PHOSPHO1 function in the initiation of 
skeletal calcification. Since PHOSPHO1 is specific for PEA 
and PCho (24,25), it is possible that Pi is generated from 
PEA and PCho through the enzymatic action of PHOSPHO1 
during the mineralization process in order to generate the Pi 
concentration needed to establish a Pi/PPi ratio permissive 
for the initial formation of HA crystal inside the MVs. The 
very low Km values for both PEA and PCho (3 and 11.4 
µM, respectively) (25) suggest that under physiological 
conditions both molecules would be rapidly hydrolyzed by 
PHOSPHO1, indicating that these compounds are therefore 
likely to be natural substrates of the enzyme. 
Annexins also play an important role in MV function 
(26-28). Annexins are Ca2+ and phospholipid binding pro-
teins, which under the right conditions can form calcium 
channels through MV membranes (26). These conditions 
include membranes with a high content of acidic phospho-
lipids (26). MVs contain annexins II, V and VI, and in such 
membranes, MV annexins appear to be associated with 
Ca2+ transport. Moreover, annexin V binds to type II and X 
collagen and these interactions stimulate its Ca2+ channel 
activities leading to increased influx of Ca2+ into liposomes 
and matrix vesicles (20,28).
The inorganic phosphate (Pi) transporter (PiT) fam-
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ily comprises Na+-dependent Pi symporters, e.g., the 
mammalian type III NaPi symporters, PiT1 and PiT2 (29). 
Moreover, the broad tissue distribution of PiT1 and PiT2 
together with their transport characteristics suggests that 
they constitute the housekeeping phosphate uptake system 
between cells and the extracellular fluid (29). In addition, 
they have been implicated in chondroblastic and osteo-
blastic mineralization (30) as well as in transdifferentiation 
of vascular smooth muscle cells to osteoblast-like cells 
in the process of vascular calcification under hyperphos-
phatemic conditions (3). Despite the essential role of Pi 
for life and the specific roles of PiT1 and PiT2 in supplying 
mammalian cells with their general Pi needs as well as the 
increasing evidence for the role of type III transporters in 
normal and pathologic calcification, only a few studies have 
addressed the physiologic function of members of the PiT 
family. Recently, Festing et al. (31) successfully generated 
conditional and null PiT1 mouse alleles to determine the in 
vivo role of PiT1, and demonstrated that PiT1 is necessary 
for embryonic development and is non-redundant, since 
PiT2 could not compensate for the loss of PiT1 and allow 
development into adulthood. Other studies have indicated 
that Pi transporters other than PiT1/2 might be involved in 
endochondral ossification (11). 
Lipid composition of MVs
In order to understand the physiological interplay be-
tween important MV-associated enzymes in the initiation 
of biomineralization, it is important to keep in mind the 
microenvironment in which these enzymes function, which 
can have a profound effect on their biological properties, 
since phospholipids play an important role in the initiation 
of the biomineralization process (4,20). Early studies of MV 
lipid composition have determined that there are significant 
differences between the lipid content of MVs and the plasma 
membranes from which they arose. Wuthier (32) reported 
these differences and hypothesized that the increase in 
acidic phospholipids in MVs was somehow associated with 
MV calcification. Further studies from his group, along with 
those of Boyan et al. (33) have proposed that MV lipids 
could act as a nucleation site for HA formation (27,34,35). 
This premise has been extensively developed under the 
idea of a “nucleational core complex”, which describes the 
interactions of MV phospholipids, Ca2+, PO43- and some 
MV proteins to form a molecular architecture that nucleates 
apatite crystallization (27,36). The acidic phospholipids 
can bind Ca2+ but, more importantly, it has been shown 
that they facilitate calcium-dependent annexin binding, 
and are permissive for annexins to form calcium channels 
through the membrane (12,26). Several lines of evidence 
suggest that glycosylphosphatidylinositol (GPI)-anchored 
proteins are commonly found to be enriched within puta-
tive cholesterol- and (glyco)sphingolipid-enriched platforms 
called “rafts” and that such association is required for the 
expression of their biological function (37,38). 
Liposome systems
Recent data (39) suggest that the location of TNAP on 
the membrane of MVs plays a role in determining substrate 
selectivity in this micro-compartment. These data suggest 
that assays of TNAP bound to MVs or to liposome-based 
systems might be more biologically relevant than assays 
done with solubilized enzyme preparations, particularly 
when studying the hydrolysis of organophosphate sub-
strates. The ability of synthetic or natural vesicles (40,41) 
to mimic the organizational structure and function of 
biomembranes makes these structures an advantageous 
and convenient experimental model to help in advancing 
our understanding of MV-mediated calcification. Table 1 
lists some advantages and disadvantages of working with 
liposome systems when compared to the use of native 
MVs. While MVs represent the native nanovesicular system 
Table 1. Comparison of the advantages and disadvantages of the use of proteoliposomes as 
biomimetics for matrix vesicles in the study of mechanisms of initiation of skeletal mineraliza-
tion. 
System Advantages Disadvantages
Matrix vesicles Native membrane structure Variable size
Native protein composition Undefined proteomic composition
Relatively stable Need live animals for isolation
Laborious isolation procedure
Proteoliposomes Easy to prepare Artificial system
Controlled lipid composition Limited stability
Controlled reconstitution of proteins
Uniform size
Controlled electrolytes
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with a full complement of active proteins, their isolation 
demands the use of animals and a laborious procedure 
that can lead to the production of membrane artifacts in 
the process. In addition, the proteomic composition of 
these MVs is still incompletely defined, although some 
proteomic studies have recently been published (15-17). 
On the other hand, proteoliposomes are easy to prepare 
and can be manufactured using different methods and with 
controlled lipid and protein composition, electrolytes and 
sizes, representing a convenient experimental model to 
mimic the organizational structure and function of natural 
biomembranes and to reproduce some essential fea-
tures of the biomineralization process (42,43). But since 
proteoliposomes are artificial systems, it is important to 
consider also the stability of the vesicles, which may affect 
the structure and function of the reconstituted enzymes. 
An important experimental consideration is the need to 
establish the appropriate lipid composition, especially the 
cholesterol content, to be used in the construction of the 
proteoliposomes since the amount of cholesterol modulates 
the fluidity of the bilayer and influences membrane features, 
such as curvature, that can affect the activity of the enzymes 
in different ways, depending on the substrates used (40). 
Moreover, the lipid membrane plays an important role as a 
nucleation agent in the biomineralization process (44,45), 
as a protective and/or activation agent (46). 
Proteoliposomes can be obtained by different prepara-
tion techniques, such as mechanical dispersion, sonica-
tion, extrusion, solvent dispersion, co-solubilization with 
detergents and reverse-phase evaporation as well as direct 
insertion after removal of the detergent (47,48). In fact, en-
zyme reconstitution varies depending on the methodology 
used for enzyme extraction, detergent used, solubilization 
method and also an adequate proportion of the lipids used 
(49-51). The method of first forming mixed micelles of vari-
ous lipids and detergent followed by the use of appropriate 
resins to remove the detergent has proved to be an effective 
means to consistently synthesize homogeneous, unilamellar 
vesicles containing transmembrane proteins and with large 
encapsulated volumes (52). In this case, it is important to 
have the protein reconstituted with the right orientation in 
the membrane, since a random orientation would confound 
the design and interpretation of experiments aimed at elu-
cidating the biological role of these proteins in the initiation 
of calcification (52). The method of direct insertion is more 
useful for proteins containing GPI anchors, since it allows 
the reconstitution of the enzymes into preformed liposomes 
by direct insertion of the anchor into the system. A combina-
tion of both liposome methodologies could be used for the 
construction of more complex systems containing different 
types of proteins, with the co-solubilization method being 
used for the incorporation of transmembrane and cytosolic 
proteins, while the GPI-anchored proteins could then be 
integrated into this preformed system by direct insertion 
of the anchor portion of the molecule. 
Two of the main lipids found in the MV membranes are 
dipalmitoylphosphatidylserine and dipalmitoylphosphati-
dylcholine (DPPC) and many studies have revealed that 
they play a crucial role in the biomineralization process, 
regulating both calcium entry into the MVs and formation 
of HA crystals (4,26). Using the direct insertion method and 
DPPC liposomes, Simão et al. (53) described the production 
and characterization of proteoliposomes harboring TNAP 
alone, NPP1 alone and TNAP + NPP1 together as MV 
biomimetics to further understand the interplay between 
these enzymes in the utilization of physiological substrates 
as a means of understanding the more complex interplay of 
these enzymes in intact MVs, crucial during early events of 
skeletal mineralization. The data show that MV enzymes can 
be reconstituted into liposomes of predefined composition. 
Such proteoliposomes proved to be useful in the study of 
the kinetic interplay of two enzymes present together on 
biomembrane mimetics when presented with physiological 
substrates relevant to the biomineralization process. These 
studies were validated by simultaneous studies on isolated 
MVs. Thus, Ciancaglini et al. (54) examined substrate uti-
lization by isolated osteoblast-derived MVs, where these 
and other enzymes are present together in a physiologi-
cal biological compartment, reporting the relative ability of 
wild-type MVs, as well as MVs deficient in TNAP, NPP1 
or PHOSPHO1 to utilize the substrates ATP, ADP and PPi 
under physiological conditions. TNAP- and PHOSPHO1-
deficient MVs showed reduced calcification ability, while 
NPP1-deficient MVs hypercalcified, demonstrating that the 
cooperativity as well as the competition of TNAP, NPP1 and 
PHOSPHO1 for the biomineralization substrates provides 
an additional level of regulation of metabolite flow for the 
control of the calcification process.
The size of natural osteoblast- and chondrocyte-derived 
MVs varies from 20 to 300 nm in diameter and it is not known 
if a single cell produces multiple sub-classes of MVs or only 
one class at a time (39,55). The size of TNAP proteolipo-
somes reconstituted from DPPC was 300 nm, as determined 
by dynamic light scattering (53), and thus is comparable to 
the median size of natural MVs (39) and can adequately 
serve as a vesicular mimetic system to examine TNAP 
function in the context of a lipid membrane environment that 
mimics the MV environment. Electron microscopy of empty 
DPPC liposomes (Figure 2A) and TNAP-proteoliposomes 
(Figure 2B) showed that enzyme reconstitution does not 
affect the morphology of the liposomes. 
Simão et al. (53) showed that the specific phospholipid 
microenvironment of MVs strongly influences the catabolism 
of the various physiological substrates of biomineraliza-
tion by TNAP and NPP1, as well as their relative weight 
in catabolism. It further suggests that the mechanistic 
study of these enzymes and their pathological mutants in 
biomineralization would, therefore, be better conducted in 
relevant liposomes rather than in solution. Most previous 
work on MVs has focused on their disassembly to determine 
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chemical composition, and on assays to elucidate how 
they function in mineralization. The proteoliposome system 
provides a means of reconstituting lipid vesicles that will 
function like MVs. There have been previous attempts to 
simulate MV mineralization using multilamellar liposomal 
systems (44,45,56,57). More recently, liposomes containing 
various proportions of anionic and neutral phospholipids and 
cholesterol were used to study the ability of annexin V to 
facilitate Ca2+ uptake (26). However, an accurate model of 
MVs must entail a unilamellar system closely approximating 
the size, lipid, electrolyte, and protein composition of native 
MVs that is capable of inducing mineralization.
Proteoliposomes as MV biomimetics
Such an MV biomimetic proteoliposome system would 
be useful for many important translational applications. 
The enzymatic defects associated with disease-causing 
mutations in the TNAP molecule, such as those found in 
hypophosphatasia (58) could be further eluci-
dated in a membrane vesicle that better mimics 
their in vivo biological environment. Since this 
artificial vesicular system adequately mimics 
the kinetic behavior of the enzymes in the 
natural vesicular MV environment (53), this 
proteoliposome system can be used for the 
screening of small molecule compounds able 
to modulate (inhibit or activate) the activity of 
MV enzymes for potential therapeutic uses 
(59,60). Such an approach seems indicated, 
especially when these compounds bear 
organic moieties capable of interacting with 
membrane phospholipids, directly or indirectly 
via Ca2+ ions present in the mineralizing mi-
croenvironment. A liposome environment will 
mimic the phospholipid-modified availability of 
organic substrates, inhibitors and modulators 
to membrane-bound enzymes, thus allow-
ing the study of enzyme catalysis in a more 
physiological manner than with solubilized 
enzymes.
This nascent in vitro experimental sys-
tem will also allow the construction of pro-
gressively more complex proteoliposomes 
containing PHOSPHO1, PiT1/2, ANK, an-
nexins, etc. that closely simulate the lipid, 
size, electrolyte, and protein composition 
of native MVs, and that also reproduce the 
kinetic properties of native MV in the forma-
tion of calcium phosphate minerals, with the 
ultimate goal of replicating in vitro the key events leading 
to the initiation of HA crystal formation in chondrocyte- and 
osteoblast-derived MVs. Once the proteoliposomes have 
been built and characterized, these vesicles can be added 
to fixed amounts of MVs, wild-type or deficient in specific 
enzymes, as a way of modulating their in vitro calcification 
properties. Those experiments would validate the use of 
these nanovesicles in promoting or delaying calcification, 
and such an artificial nanovesicular system could also po-
tentially prove useful for the repair/treatment of craniofacial 
and other skeletal defects and to facilitate the mineralization 
of titanium-based tooth implants.
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Figure 2. Electron microscopy using negative staining of: A, Liposomes consist-
ing of dipalmitoylphosphatidylcholine (DPPC) and B, tissue-nonspecific alkaline 
phosphatase reconstituted in DPPC liposomes, both with magnification of 50X. A 
5-µL suspension of liposomes or proteoliposomes was placed on carbon-coated 
copper grids for 1 min to sediment the sample. The excess buffer was removed 
and exchanged for 2% (w/v) of an aqueous solution of uranyl-acetate for 15 s; ex-
cess uranyl-acetate was removed, grids were air-dried for 2-5 min and examined 
with a Hitachi H600A transmission electron microscope at 75 kV. Images were 
collected with an L9C cooled CCD, 11.2 megapixel camera (Special Achievement 
in innovation - SIA)
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